Ευρωπαϊκή Ένωση -
Νορβηγικά -
EMA (European Medicines Agency)
fampridine accord
accord healthcare s.l.u. - fampridine - multippel sklerose - andre nervesystemet narkotika - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
fampridine sandoz 10 mg
sandoz a/s - fampridin - depottablett - 10 mg
Ευρωπαϊκή Ένωση -
Νορβηγικά -
EMA (European Medicines Agency)
fampyra
biogen netherlands b.v. - fampridine - multippel sklerose - andre nervesystemet narkotika - fampyra angis for forbedring av gåing i voksen pasienter med multippel sklerose innen funksjonshemming (utvidet funksjonshemming status skala 4-7).
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
fampyra 10 mg
orifarm as - fampridin - depottablett - 10 mg
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
hydroxyzine bluefish 25 mg
bluefish pharmaceuticals ab - hydroksyzinhydroklorid - tablett, filmdrasjert - 25 mg
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
hydroxyzine bluefish 10 mg
bluefish pharmaceuticals ab - hydroksyzinhydroklorid - tablett, filmdrasjert - 10 mg
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
losartan medical valley 100 mg
medical valley invest ab - losartankalium - tablett, filmdrasjert - 100 mg
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
losartan medical valley 12.5 mg
medical valley invest ab - losartankalium - tablett, filmdrasjert - 12.5 mg
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
losartan medical valley 50 mg
medical valley invest ab - losartankalium - tablett, filmdrasjert - 50 mg
Ευρωπαϊκή Ένωση -
Νορβηγικά -
EMA (European Medicines Agency)
vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidemiene - lipid modifiserende midler - indicated to reduce cardiovascular risk as an adjunct to statin therapy.